CH258712A - Verfahren zur Herstellung eines koagulationshemmenden Stoffes. - Google Patents
Verfahren zur Herstellung eines koagulationshemmenden Stoffes.Info
- Publication number
- CH258712A CH258712A CH258712DA CH258712A CH 258712 A CH258712 A CH 258712A CH 258712D A CH258712D A CH 258712DA CH 258712 A CH258712 A CH 258712A
- Authority
- CH
- Switzerland
- Prior art keywords
- coagulation
- oxy
- bis
- methylene
- production
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 7
- 239000000126 substance Substances 0.000 title claims description 6
- 238000004519 manufacturing process Methods 0.000 title claims description 3
- 230000010100 anticoagulation Effects 0.000 title description 2
- 230000015271 coagulation Effects 0.000 claims description 11
- 238000005345 coagulation Methods 0.000 claims description 11
- 238000005984 hydrogenation reaction Methods 0.000 claims description 5
- 230000002401 inhibitory effect Effects 0.000 claims description 4
- 238000002844 melting Methods 0.000 claims description 4
- 230000008018 melting Effects 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 2
- 108010094028 Prothrombin Proteins 0.000 description 10
- 102100027378 Prothrombin Human genes 0.000 description 10
- 229940039716 prothrombin Drugs 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229960004072 thrombin Drugs 0.000 description 4
- 108010074860 Factor Xa Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 108090000190 Thrombin Proteins 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 206010004966 Bite Diseases 0.000 description 1
- 108010062466 Enzyme Precursors Proteins 0.000 description 1
- 102000010911 Enzyme Precursors Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- 108010000499 Thromboplastin Proteins 0.000 description 1
- 102000002262 Thromboplastin Human genes 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000003891 oxalate salts Chemical class 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/42—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
- C07D311/44—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 with one hydrogen atom in position 3
- C07D311/46—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 with one hydrogen atom in position 3 unsubstituted in the carbocyclic ring
- C07D311/48—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 with one hydrogen atom in position 3 unsubstituted in the carbocyclic ring with two such benzopyran radicals linked together by a carbon chain
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH258712T | 1946-02-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH258712A true CH258712A (de) | 1948-12-15 |
Family
ID=4472772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH258712D CH258712A (de) | 1946-02-20 | 1946-02-20 | Verfahren zur Herstellung eines koagulationshemmenden Stoffes. |
Country Status (2)
| Country | Link |
|---|---|
| CH (1) | CH258712A (en, 2012) |
| NL (1) | NL61550C (en, 2012) |
-
0
- NL NL61550D patent/NL61550C/xx active
-
1946
- 1946-02-20 CH CH258712D patent/CH258712A/de unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL61550C (en, 2012) |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE19753071T1 (de) | Biomassezusammensetzungen mit aktiviertem Pektin, Produkte und Verfahren zur Herstellung | |
| CH258712A (de) | Verfahren zur Herstellung eines koagulationshemmenden Stoffes. | |
| DE2133572A1 (de) | Verfahren zur herstellung von pektinen | |
| DE415871C (de) | Verfahren zur Herstellung von hydriertem Kautschuk | |
| DE654447C (de) | Verfahren zur Stabilisierung von eisenempfindlichen Diazoloesungen | |
| DE838746C (de) | Verfahren zur Herstellung von 2-AEthylhexanal-(1) oder 2-AEthylhexanol-(1) | |
| DE920780C (de) | Verfahren zur Herstellung von wasserloeslichen Staerke-Derivaten | |
| DE839937C (de) | Verfahren zur Herstellung eines Benzilsaeurederivates | |
| DE805519C (de) | Verfahren zur Herstellung von therapeutisch wirksamen Kobaltkomplex-Verbindungen | |
| DE619348C (de) | Verfahren zur Herstellung von reinem Diacetyl aus Holzessig oder anderen Diacetyl enthaltenden Gemischen | |
| DE611373C (de) | Verfahren zur Darstellung von Fettsaeurederivaten | |
| DE970964C (de) | Verfahren zur Polymerisation von Acrylsaeurenitril allein oder im Gemisch mit anderen Vinyl-Verbindungen | |
| DE224979C (en, 2012) | ||
| AT67783B (de) | Verfahren zur Herstellung von wasserlöslichen Silber-Eiweißverbindungen. | |
| DE893793C (de) | Verfahren zur Herstellung eines Vorproduktes fuer die Erzeugung von Kunstharzen aus Lignosulfonsaeure | |
| DE721684C (de) | Entkaelkungsmittel | |
| AT263814B (de) | Verfahren zur Herstellung eines neuen Poly-γ-propylsulfosäureäthers des Inulins | |
| DE1793227C3 (de) | Verfahren zur diskontinuierlichen Herstellung von Alkalisalzen der Nitrilotriessigsäure | |
| DE530470C (de) | Verfahren zur Herstellung von Acetylcellulose | |
| DE719366C (de) | Verfahren zur Herstellung von Salzen der N-Acylderivate der p-Aminophenylstibinsaeure | |
| CH268690A (de) | Verfahren zur Darstellung von Adermin (Vitamin B6). | |
| AT83840B (de) | Verfahren zur Herstellung von Torfbriketts. | |
| DE484838C (de) | Verfahren zur Darstellung von ª‰-Aryl-ª‡-aminopropionsaeuren | |
| DE1173093B (de) | Verfahren zur Herstellung von 3ª-Amino-11-keto-20, 20-bis-hydroxymethyl-5ª-pregnanbzw. von Salzen desselben | |
| DE2839565A1 (de) | Verfahren zur reindestillation von buchenholzteer-kreosot |